Comparison of CDH1 Penetrance Estimates in Clinically Ascertained Families vs Families Ascertained for Multiple Gastric Cancers-Reference-Cited by-同舟云学术

Comparison of CDH1 Penetrance Estimates in Clinically Ascertained Families vs Families Ascertained for Multiple Gastric Cancers

Published:2019-09-01 Issue:9 Volume:5 Page:1325
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Roberts Maegan E.¹,Ranola John Michael O.²,Marshall Megan L.¹,Susswein Lisa R.¹,Graceffo Sara¹,Bohnert Kelsey¹³,Tsai Ginger²,Klein Rachel T.⁴,Hruska Kathleen S.¹,Shirts Brian H.²

Affiliation:

1. GeneDx, Gaithersburg, Maryland

2. Department of Laboratory Medicine, University of Washington, Seattle, Washington

3. Genetic Counseling Program, Graduate School of Public Health, University of Pittsburgh, Pennsylvania

4. My Gene Team, Miami, Florida

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2737090/jamaoncology_roberts_2019_oi_190033.pdf

Reference21 articles.

1. Identification of germ-line E-cadherin mutations in gastric cancer families of European origin.;Gayther;Cancer Res,1998

2. Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers.;van der Post;J Med Genet,2015

3. Familial gastric cancer: overview and guidelines for management;Caldas;J Med Genet,1999

4. Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research.;Fitzgerald;J Med Genet,2010

5. Unexpected CDH1 mutations identified on multigene panels pose clinical management challenges;Lowstuter;JCO Precis Oncol

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Costs of Cancer Prevention: Physical and Psychosocial Sequelae of Risk-Reducing Total Gastrectomy;Journal of Clinical Oncology;2024-02-01

2. Screening, Surveillance, and Prevention of Esophageal and Gastric Cancers;Gastrointestinal Oncology ‐ A Critical Multidisciplinary Team Approach 2e;2024-01-23

3. Pioneering use of genetic analysis forCDH1to identify candidates for prophylactic total gastrectomy to prevent hereditary diffuse gastric cancer;eGastroenterology;2023-12

4. Defining features of hereditary lobular breast cancer due to CDH1 with magnetic resonance imaging and tumor characteristics;npj Breast Cancer;2023-09-27

5. Clinical Implication of CDH1 Mutations in Genetic Testing for Diffuse Gastric Cancer Patients;Oncology;2023-09-19